EVIDENCE FOR INVOLVEMENT OF BOTH D1 AND D2 RECEPTORS IN MAINTAINING COCAINE SELF-ADMINISTRATION

被引:91
作者
BRITTON, DR
CURZON, P
MACKENZIE, RG
KEBABIAN, JW
WILLIAMS, JEG
KERKMAN, D
机构
关键词
COCAINE; SELF-ADMINISTRATION; A69024; SCH-23390; YM-09151-2; DOPAMINE; D1; RECEPTORS; D2; RATS;
D O I
10.1016/0091-3057(91)90052-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Rats trained to self-administer cocaine (0.75 mg/kg/infusion) on an FR-5 schedule were treated with selective D1 or D2 antagonists. A69045, a D1 antagonist with no appreciable affinity for 5-HT receptors increased cocaine self-administration to 147, 172 and 167% of baseline at doses of 2.5, 5.0 or 10.0-mu-mol/kg, SC respectively. SCH-23390 (0.007, 0.015 and 0.030-mu-mol/kg, SC) increased self-administration to 116, 147 and 165% of baseline, respectively. Both D1 antagonists decreased responding in some animals at the highest dose tested. The D2 antagonist YM-09151-2 showed a similar profile, increasing cocaine self-administration at 0.01 and 0.016-mu-mol/kg, SC and suppressing responding by most animals at the dose of 0.03-mu-mol/kg, SC. These data give further support to the hypothesis that both D1 and D2 receptors are involved in maintaining cocaine self-administration.
引用
收藏
页码:911 / 915
页数:5
相关论文
共 34 条
[1]   REGIONAL DISTRIBUTION OF DOPAMINE-D1 AND DOPAMINE-D2 RECEPTORS IN THE NUCLEUS ACCUMBENS OF THE RAT [J].
ALLIN, R ;
RUSSELL, V ;
LAMM, M ;
TALJAARD, J .
BRAIN RESEARCH, 1989, 501 (02) :389-391
[5]   RECEPTOR SUBTYPE-SPECIFIC DOPAMINERGIC AGENTS AND CONDITIONED BEHAVIOR [J].
BENINGER, RJ ;
HOFFMAN, DC ;
MAZURSKI, EJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1989, 13 (2-3) :113-122
[6]   EFFECTS OF EXTINCTION, PIMOZIDE, SCH 23390, AND METOCLOPRAMIDE ON FOOD-REWARDED OPERANT RESPONDING OF RATS [J].
BENINGER, RJ ;
CHENG, M ;
HAHN, BL ;
HOFFMAN, DC ;
MAZURSKI, EJ ;
MORENCY, MA ;
RAMM, P ;
STEWART, RJ .
PSYCHOPHARMACOLOGY, 1987, 92 (03) :343-349
[7]   THE D-1 DOPAMINE RECEPTOR ANTAGONIST SCH 23390 ALSO INTERACTS POTENTLY WITH BRAIN-SEROTONIN (5-HT2) RECEPTORS [J].
BISCHOFF, S ;
HEINRICH, M ;
SONNTAG, JM ;
KRAUSS, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :367-370
[8]   INTERACTION OF THE D1-RECEPTOR ANTAGONIST SCH-23390 WITH THE CENTRAL 5-HT SYSTEM - RADIOLIGAND BINDING-STUDIES, MEASUREMENTS OF BIOCHEMICAL PARAMETERS AND EFFECTS ON L-5-HTP SYNDROME [J].
BISCHOFF, S ;
HEINRICH, M ;
KRAUSS, J ;
SILLS, MA ;
WILLIAMS, M ;
VASSOUT, A .
JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4) :107-120
[9]  
BRITTON DR, 1990, CURR OPIN NEUROL NEU, V3, P552
[10]   BLOCKADE OF COCAINE REINFORCEMENT IN RATS WITH DOPAMINE RECEPTOR BLOCKER PIMOZIDE, BUT NOT WITH NORADRENERGIC BLOCKERS PHENTOLAMINE OR PHENOXYBENZAMINE [J].
DEWIT, H ;
WISE, RA .
CANADIAN JOURNAL OF PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE, 1977, 31 (04) :195-203